In osteosarcoma and glioblastoma, TRPM8 promotes cell proliferation through the modulation of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) expression (Wang et al., 2013; Alptekin et al., 2015; Zeng et al., 2019). Here, CDK4 is linked to osteosarcoma.